Delivery Order SPE2DB20D2104-SPE2DB24FS67X

Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,091.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 mg tablets, a medication used to treat depression. This contract award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $17,967.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 mg tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $29,278.53, is for the delivery of Citalopram HBR 40 mg tablets, a medication used to treat depression. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,426.16 firm fixed-price delivery order contract covers the supply of 4,562,275,404 units of Citalopram HBR 40 mg tablets, a medication used to treat mental health conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,026.78 firm fixed-price delivery order is for the supply of 500 units of Citalopram Hydrobromide 40 mg tablets, a prescription medication. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025....
This federal contract award, valued at $10,286.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of 4562731594 CITALOPRAM HBR 40 MG TABLET 500S, a pharmaceutical product...
This federal contract award, valued at $2,070.19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,045,767 units of Citalopram HBR 40 mg tablets, a medication used to treat depression. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which runs through November 2026. The IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $85,901.33 firm-fixed-price delivery order is for the supply of Citalopram HBR 40 mg tablets, a medication used to treat depression. The contract has an ultimate completion date of September 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award, valued at $6,241.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 MG Tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
This federal contract award, valued at $11,577.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,563,797,852 tablets of Citalopram HBR 40 mg, a medication used to treat depression. The award has a completion date of February 29, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS67X
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $14,385.50 firm fixed-price delivery order is for the supply of Citalopram HBR 40mg tablets, a medication used to treat mental health conditions.

The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs.

The award demonstrates Amerisourcebergen Drug Corp's role as a critical supplier of essential pharmaceutical and medical commodities to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 5/14/25, 10:41 AM